Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 7/20 | 0.58 |
| ▸ | PPARG | P37231 | 6/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 2/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | RAB9A | P51151 | 1/20 | 0.51 |
| ▸ | SCN4A | P35499 | 2/20 | 0.47 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.46 |
| ▸ | MAOB | P27338 | 2/20 | 0.45 |
| ▸ | MAOA | P21397 | 1/20 | 0.45 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21895800 | 1.00 | PPARA (0.58) | PPARAPPARGCYP1A2MEN1KMT2A | |
| SCHEMBL28619870 | 1.00 | PPARA (0.58) | PPARAPPARGCYP1A2MEN1KMT2A | |
| Water SCHEMBL11798405 | 0.98 | PPARA (0.56) | PPARAPPARGCYP1A2MEN1KMT2A | |
| SCHEMBL11536518 | 0.95 | PPARA (0.54) | PPARAPPARGCYP1A2MEN1KMT2A | |
| SCHEMBL11476340 | 0.92 | PPARG (0.51) | PPARAPPARGCYP1A2MEN1KMT2A | |
| SCHEMBL4753580 | 0.92 | HPGD (0.54) | PPARAPPARGCYP1A2MEN1KMT2A | |
| Hydrochloric Acid SCHEMBL10967781 | 0.91 | HPGD (0.53) | PPARAPPARGCYP1A2MEN1KMT2A | |
| SCHEMBL11537007 | 0.91 | PPARG (0.50) | PPARAPPARGCYP1A2MEN1KMT2A | |
| SCHEMBL11539982 | 0.89 | ALDH1A1 (0.50) | PPARAPPARGCYP1A2MEN1KMT2A | |
| Bromomethane SCHEMBL10967617 | 0.89 | HPGD (0.51) | PPARAPPARGCYP1A2MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 323 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119504432-A | Method for preparing clofibrate by using sulfur hexafluoride | 国网安徽省电力有限公司电力科学研究院 | 2025-02-25 | — | — | CN | claimed |
| US-20210137096-A1 | COMPOSITIONS AND METHODS FOR CONTROLLING PLANT OR CROP SIZE IN A CONTROLLED ENVIRONMENT | BASF AGRICULTURAL SOLUTIONS US LLC | 2021-05-13 | — | — | US | claimed |
| CN-112494469-A | Application of metformin in preparation of medicament for preventing and/or treating scar | 吴学雷 | 2021-03-16 | — | — | CN | claimed |
| EP-3731618-A1 | COMPOSITIONS AND METHODS FOR CONTROLLING PLANT OR CROP SIZE IN A CONTROLLED ENVIRONMENT | BASF Agricultural Solutions Seed US LLC (US) | 2020-11-04 | — | — | EP | claimed |
| CN-211837872-U | Temperature-adjustable p-chlorophenoxyisobutyric acid preparation reaction kettle | 常州市天华制药有限公司 | 2020-11-03 | — | — | CN | claimed |
| EP-2599382-B1 | METHOD FOR GENE TRANSFER INTO PLANT BELONGING TO GENUS HORDEUM USING AGROBACTERIUM BACTERIUM, AND METHOD FOR PRODUCTION OF TRANSGENIC PLANT OF PLANT BELONGING TO GENUS HORDEUM | JAPAN TOBACCO INC (JP) | 2017-07-19 | — | — | EP | claimed |
| EP-2016085-B9 | TRANSITION METAL COMPLEXES FOR INHIBITING RESISTANCE IN THE TREATMENT OF CANCER AND METASTASIS | ECOLE POLYTECHNIQUE FÉDÉRALE DE LAUSANNE EPFL (CH) | 2015-12-30 | — | — | EP | claimed |
| EP-2016085-B1 | TRANSITION METAL COMPLEXES FOR INHIBITING RESISTANCE IN THE TREATMENT OF CANCER AND METASTASIS | ECOLE POLYTECHNIQUE FÉDÉRALE DE LAUSANNE EPFL (CH) | 2015-08-05 | — | — | EP | claimed |
| US-20150190362-A1 | TRANSITION METAL COMPLEXES FOR INHIBITING RESISTANCE IN THE TREATMENT OF CANCER AND METASTASIS | ECOLE POLYTECHNIQUE FED LAUSANNE EPFL (CH) | 2015-07-09 | — | — | US | claimed |
| US-9018199-B2 | Transition metal complexes for inhibiting resistance in the treatment of cancer and metastasis | ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL) (CH) | 2015-04-28 | — | — | US | claimed |
| WO-2001020972-A1 | METHOD FOR MATURATION OF CONIFER SOMATIC EMBRYOS | WOODY PLANT BIOTECH APS (DK) | 2001-03-29 | — | — | WO | claimed |
| WO-2000059875-A2 | NOVEL INHIBITORS OF FORMATION OF ADVANCED GLYCATION ENDPRODUCTS (AGE'S) | CITY OF HOPE (US) | 2000-10-12 | — | — | WO | claimed |
| EP-0954596-A1 | ENHANCED PRODUCTION OF TAXANES BY CELL CULTURES OF $i(TAXUS) SPECIES | PHYTON, INC. (US) | 1999-11-10 | — | — | EP | claimed |
| WO-1997044476-A1 | ENHANCED PRODUCTION OF TAXANES BY CELL CULTURES OF TAXUS SPECIES | PHYTON, INC. (US) | 1997-11-27 | — | — | WO | claimed |
| EP-0194221-B1 | PROCESS FOR THE PREPARATION OF THE PARA-CHLOROPHENOL ESTER OF PARA-CHLOROPHENOXYBUTYRIC ACID | CORTIAL S.A. (FR) | 1988-06-08 | — | — | EP | claimed |
| US-4638082-A | Method of producing the p-chlorophenol ester of p-chlorophenoxyisobutyric acid | SOCIETE CORIAL, S.A. (FR) | 1987-01-20 | — | — | US | claimed |
| US-4249014-A | ANALGESICS, ANTISPASMODICS, ANTIINFLAMMATORY VASODILATORS | INNOTHERA (FR) | 1981-02-03 | — | — | US | claimed |
| US-4186136-A | COAGULANTS, ANTISPASMODIC AGENTS, ANALGESICS, ANTIINGLAMMATORY AGENTS, VASODILATION | INNOTHERA (FR) | 1980-01-29 | — | — | US | claimed |
| US-4126636-A | PROCESS OF PRODUCING THE MAGNESIUM SALT OF P-CHLOROPHENOXYISOBUTYRIC ACID | PAUL HAUSER - CHEPHARIN, CHEMISCH-PHARMAZEUTISCHE INDUSTRIEGESELLSCHAFT IN KLAGENFURT (AT) | 1978-11-21 | — | — | US | claimed |
| US-4031240-A | HYPOCHOLESTEROLEMIC, HYPOTRIGLYCIDEMIC, HYPOLIPIDEMIC | LABORATORIOS DEL DR. ESTEVE S.A. (ES) | 1977-06-21 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150190362-A1 | TRANSITION METAL COMPLEXES FOR INHIBITING RESISTANCE IN THE TREATMENT OF CANCER AND METASTASIS | SLC39A3, FABP2, APC | PPARA 3795/4885PPARG 3922/4885CYP1A2 3553/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.